Biomedical Venture

In 1998, BankInvest established the first of several venture funds focusing on biotechnology. Today, BankInvest Biomedical Venture has more than EUR 400 million under management. The majority of these are invested in research-based European biotechnology companies dedicated to developing profitable pharmaceuticals for the treatment of human diseases. The funds investments make up a portfolio of more than 30 European and US companies.

Biomedical Venture

NorthCap Partners
 

NorthCap Partners are working with the best entrepreneurs on consistently building successful businesses.

NorthCap Partners is a Danish venture capital company formed by a team of experienced professionals with a strong track record of developing technology businesses in the IT field.

 NorthCap Partners

New Energy Solutions
 

P/S BankInvest New Energy Solutions is focussed on three important areas within the energy sector: Renewable energy, distributed energy and ways of making the traditional energy sector more effective.

New Energy Solutions

PENM
 

BankInvest is managing two funds (PENM I & II) with a combined capital of USD 300 million.

PENM invests exclusively in companies in Africa as well as Central and South East Asia. PENM's investment focus is on unlisted companies with a proven track record and a strong future development potential.

The BankInvest Group has for 20 years been committed to emerging markets and is the largest Scandinavian institutional investor in emerging markets.

Private Equity New Markets